ESP/PIF for Sternotomy

NCT ID: NCT04985500

Last Updated: 2025-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

225 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-09

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of two types of peripheral nerve blocks, specifically erector spinal plane (ESP) block and pecto-intercostal fascial (PIF) plane block.

90 subjects, from 18-85 years of age, undergoing cardiac surgery with median sternal incision will be enrolled at Mount Sinai Morningside Hospital Center. Study participation will last from the time of pre-operative evaluation to 72 hours after surgery. Subjects will be randomly assigned to receive 1 of the 3 different regimens at the beginning of surgery. Opioid consumption and pain scores after surgery will be evaluated. Though unlikely, risks include systemic absorption of local anesthetic, which can result in both central nervous system and cardiac toxicity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgery Sternotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Patients will be assigned randomly using a computer-generated table of numbers to one of the three groups: 1) ESP group, 2) PIF group, or 3) no block group.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
The anesthesiologist assessing the patient will be blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ESP group

Patient will receive ESP block with ultrasound guidance the transverse process of the vertebra at T7 is visualized and 20 mL of 0.25% bupivacaine will be injected between the transverse process and the erector spinae muscle on each side using a 21-gauge block needle.

Group Type EXPERIMENTAL

ESP block

Intervention Type PROCEDURE

peripheral nerve block

Ultrasound

Intervention Type PROCEDURE

Ultrasound guidance

Bupivacain

Intervention Type DRUG

10-20 mL of 0.25% bupivacaine

PIF group

Patient will receive PIF block after intubation with ultrasound placed 1-2 cm lateral to the sternal border and the pectoralis major and external intercostal muscles are visualized at the level of ribs 3-4 where 10 mL of 0.25% bupivacaine will be injected on each side using a 21-gauge block needle.

Group Type EXPERIMENTAL

PIF block

Intervention Type PROCEDURE

peripheral nerve block

Ultrasound

Intervention Type PROCEDURE

Ultrasound guidance

Bupivacain

Intervention Type DRUG

10-20 mL of 0.25% bupivacaine

No Block group

Patient will not receive block.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESP block

peripheral nerve block

Intervention Type PROCEDURE

PIF block

peripheral nerve block

Intervention Type PROCEDURE

Ultrasound

Ultrasound guidance

Intervention Type PROCEDURE

Bupivacain

10-20 mL of 0.25% bupivacaine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

erector spinal plane block pecto-intercostal fascial plane block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults 18-85 years old
* Scheduled to undergo cardiac procedures involving sternotomy
* All genders

Exclusion Criteria

* ASA class V
* Urgent or emergent surgery
* Contraindications to administration of local anesthesia (e.g. local anesthetic allergy)
* History of substance abuse or chronic opioid use
* Patient refusal or inability to consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Icahn School of Medicine at Mount Sinai

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Nima Shariat

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ali Shariat, M.D.

Role: PRINCIPAL_INVESTIGATOR

Mount Sinai West and Morningside Hospitals

Himani Bhatt, D.O.

Role: STUDY_DIRECTOR

Mount Sinai West and Morningside Hospitals

Shenghao Fang, M.D.

Role: STUDY_DIRECTOR

Mount Sinai West and Morningside Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Sinai Morningside Hospital

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY-20-01473

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ESP Blocks for Posterior Spinal Fusion
NCT07228039 NOT_YET_RECRUITING PHASE4